» Articles » PMID: 29791908

A De Novo KCNA1 Mutation in a Patient with Tetany and Hypomagnesemia

Overview
Journal Nephron
Publisher Karger
Specialty Nephrology
Date 2018 May 24
PMID 29791908
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Mutations in the KCNA1 gene encoding the voltage-gated potassium (K+) channel Kv1.1 have been linked to rare neurological syndromes, episodic ataxia type 1 (EA1) and myokymia. In 2009, a KCNA1 mutation was identified in a large family with autosomal dominant hypomagnesemia. Despite efforts in establishing a genotype-phenotype correlation for the wide variety of symptoms in EA1, little is known on the serum magnesium (Mg2+) levels in these patients. In the present study, we describe a new de novo KCNA1 mutation in a Polish patient with tetany and hypomagnesemia. Electrophysiological and biochemical analyses were performed to determine the pathogenicity of the mutation. A female patient presented with low serum Mg2+ levels, renal Mg2+ wasting, muscle cramps, and tetanic episodes. Whole exome sequencing identified a p.Leu328Val mutation in KCNA1 encoding the Kv1.1 K+ channel. Electrophysiological examinations demonstrated that the p.Leu328Val mutation caused a dominant-negative loss of function of the encoded Kv1.1 channel. Cell surface biotinylation showed normal plasma membrane expression. Taken together, this is the second report linking KCNA1 with hypomagnesemia, thereby emphasizing the need for further evaluation of the clinical phenotypes observed in patients carrying KCNA1 mutations.

Citing Articles

Native American ataxia medicines rescue ataxia-linked mutant potassium channel activity via binding to the voltage sensing domain.

Manville R, Freites J, Sidlow R, Tobias D, Abbott G Nat Commun. 2023; 14(1):3281.

PMID: 37280215 PMC: 10244465. DOI: 10.1038/s41467-023-38834-6.


Novel Genetic Variants Expand the Functional, Molecular, and Pathological Diversity of Channelopathy.

Paulhus K, Glasscock E Int J Mol Sci. 2023; 24(10).

PMID: 37240170 PMC: 10219020. DOI: 10.3390/ijms24108826.


Genetic Links to Episodic Movement Disorders: Current Insights.

Garg D, Mohammad S, Shukla A, Sharma S Appl Clin Genet. 2023; 16:11-30.

PMID: 36883047 PMC: 9985884. DOI: 10.2147/TACG.S363485.


Potassium Channels as a Target for Cancer Therapy: Current Perspectives.

Zuniga L, Cayo A, Gonzalez W, Vilos C, Zuniga R Onco Targets Ther. 2022; 15:783-797.

PMID: 35899081 PMC: 9309325. DOI: 10.2147/OTT.S326614.


Possible role for rare TRPM7 variants in patients with hypomagnesaemia with secondary hypocalcaemia.

Vargas-Poussou R, Claverie-Martin F, Prot-Bertoye C, Carotti V, van der Wijst J, Perdomo-Ramirez A Nephrol Dial Transplant. 2022; 38(3):679-690.

PMID: 35561741 PMC: 9976740. DOI: 10.1093/ndt/gfac182.


References
1.
DAdamo M, Hasan S, Guglielmi L, Servettini I, Cenciarini M, Catacuzzeno L . New insights into the pathogenesis and therapeutics of episodic ataxia type 1. Front Cell Neurosci. 2015; 9:317. PMC: 4541215. DOI: 10.3389/fncel.2015.00317. View

2.
Eunson L, Rea R, Zuberi S, Youroukos S, Panayiotopoulos C, Liguori R . Clinical, genetic, and expression studies of mutations in the potassium channel gene KCNA1 reveal new phenotypic variability. Ann Neurol. 2000; 48(4):647-56. View

3.
Shook S, Mamsa H, Jen J, Baloh R, Zhou L . Novel mutation in KCNA1 causes episodic ataxia with paroxysmal dyspnea. Muscle Nerve. 2007; 37(3):399-402. DOI: 10.1002/mus.20904. View

4.
Lek M, Karczewski K, Minikel E, Samocha K, Banks E, Fennell T . Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016; 536(7616):285-91. PMC: 5018207. DOI: 10.1038/nature19057. View

5.
Tristan-Clavijo E, Scholl F, Macaya A, Iglesias G, Rojas A, Lucas M . Dominant-negative mutation p.Arg324Thr in KCNA1 impairs Kv1.1 channel function in episodic ataxia. Mov Disord. 2016; 31(11):1743-1748. DOI: 10.1002/mds.26737. View